Synthesis and therapeutic evaluation of [211At]YF2: a next generation PSMAtargeted radiopharmaceutical
Publication
, Conference
Feng, Y; Meshaw, R; Vaidyanathan, G; Pomper, M; Zalutsky, M
Published in: JOURNAL OF NUCLEAR MEDICINE
2023
Duke Scholars
Published In
JOURNAL OF NUCLEAR MEDICINE
EISSN
1535-5667
ISSN
0161-5505
Publication Date
2023
Volume
64
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Feng, Y., Meshaw, R., Vaidyanathan, G., Pomper, M., & Zalutsky, M. (2023). Synthesis and therapeutic evaluation of [211At]YF2: a next generation PSMAtargeted radiopharmaceutical. In JOURNAL OF NUCLEAR MEDICINE (Vol. 64).
Feng, Yutian, Rebecca Meshaw, Ganesan Vaidyanathan, Martin Pomper, and Michael Zalutsky. “Synthesis and therapeutic evaluation of [211At]YF2: a next generation PSMAtargeted radiopharmaceutical.” In JOURNAL OF NUCLEAR MEDICINE, Vol. 64, 2023.
Feng Y, Meshaw R, Vaidyanathan G, Pomper M, Zalutsky M. Synthesis and therapeutic evaluation of [211At]YF2: a next generation PSMAtargeted radiopharmaceutical. In: JOURNAL OF NUCLEAR MEDICINE. 2023.
Feng, Yutian, et al. “Synthesis and therapeutic evaluation of [211At]YF2: a next generation PSMAtargeted radiopharmaceutical.” JOURNAL OF NUCLEAR MEDICINE, vol. 64, 2023.
Feng Y, Meshaw R, Vaidyanathan G, Pomper M, Zalutsky M. Synthesis and therapeutic evaluation of [211At]YF2: a next generation PSMAtargeted radiopharmaceutical. JOURNAL OF NUCLEAR MEDICINE. 2023.
Published In
JOURNAL OF NUCLEAR MEDICINE
EISSN
1535-5667
ISSN
0161-5505
Publication Date
2023
Volume
64
Related Subject Headings
- Nuclear Medicine & Medical Imaging
- 3202 Clinical sciences
- 1103 Clinical Sciences